In vivo/in vitro studies on the effects of cyclophosphamide on growth and differentiation of hamster palate

Anti-Cancer Drugs

Volumn 7, Issue 2, 1996, Pages 204-212

  Shah, R M ^a   Izadnegahdar, M F ^a   Hehn, B M ^a   Young, A V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

collagen; cyclophosphamide; glycosaminoglycan; hamster; palate; vitamins

Indexed keywords

COLLAGEN; CYCLOPHOSPHAMIDE; GLUCOSAMINE; GLYCOSAMINOGLYCAN; PROLINE; PYRIDOXINE; RADIOISOTOPE; THIAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DEVELOPMENT; DNA SYNTHESIS; EMBRYO; FEMALE; GLYCOSAMINOGLYCAN METABOLISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER SLICE; METABOLIC ACTIVATION; NONHUMAN; PALATE; PREGNANCY; PRIORITY JOURNAL; SYRIAN HAMSTER; TERATOGENICITY; TISSUE GROWTH;

EID: 0030010334     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199602000-00010     Document Type: Article

References (76)

1. Colvin M. Cyclophosphamide and analogues In: Crooke ST, Prestayko AW, eds. Cancer and chemotherapy. New York: Academic Press 1981; 8: 25-36.
2. Mackie EJ. Immunosuppressive effects of cyclophosphamide in pigs. Am J Vet Res 1981; 42: 189-94.
3. Lee C, Kerrigan CL, Picard-Ami LA, et al. Cyclophosphamide-induced neutropenia: effect on post-ischemic skinflap survival. Plast Reconstruct Surg 1992; 89: 1092-7.
4. Gerlinger P, Ruch JV, Culvert J, et al. Action du cyclophosphamide sur la formation de l'embryon. C R Soc Biol 1963; 157: 173-6.
5. Chaube S, Kury G, Murphy ML, et al. Teratogenic effects of cyclophosphamide (NSC-26271) in the rat. Cancer Chemotherap Res 1967; 512: 363-76.
6. Gibson JE, Baker BA. The teratogenicity of cyclophosphamide in mice. Cancer Res 1968; 28: 475-80.
7. Singh SS. The teratogenicity of cyclophosphamide (Endostan Asta) in rats. Indian J Med Res 1971; 59: 428-35.
8. Ashby RL, Davis B, Dewhurst R, et al. Aspects of teratology of cyclophosphamide. Cancer Treat Rep 1976; 60: 477-82.
9. Spielmann H, Eibs HG, Merker HJ, et al. Effects of cyclophosphamide treatment before implantation on the development of rat embryos after implantation. J Embryo Exp Morph 1977; 41: 65-78.
10. McClure HM, Wilk AL, Horigan EA, et al. Induction of craniofacial malformations in rhesus monkey (Macaca muleta) with cyclophosphamide. Cleft Palate J 1979; 16: 248-56.
11. Gilani S, Chatzinoff M. Embryopathic effects of cyclophosphamide. Environ Res 1983; 31: 296-301.
12. Jayaseelan N, Singh S, Padmanabhan R, et al. Dose-dependent toxicity and reduction deformity of hind limbs in rat fetuses - an experimental study. Indian J Exp Biol 1984; 22: 135-40
13. Shah RM, Arcadi F, Suen R, et al. Effects of cyclophosphamide on the secondary palate development in Golden Syrian hamster. Teratology, morphology and morphometry. J Craniofac Genet Dev Biol 1989; 9: 381-96.
14. Lenarczyk M, Dobrzynska MM, Slowikowaska MG, et al. Evaluation of spermatogenic response of mice to the induction of mutation by combined treatment with X-rays and antineoplastic drugs. Radiat Environ Biophys 1994; 33: 219-31.
15. Brock N, Hohorst HJ. Metabolism of cyclophosphamide. Cancer 1967; 20: 900-4.
16. Brock N, Gross R, Hohorst HJ, et al. Activation of cyclophosphamide in man and animals. Cancer 1971; 27: 1512-29.
17. Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man: chromosomal abberation, antifertility effects, congenital malformations, and carcinogenic potential. Adv Cancer Res 1975; 36: 2019-2025.
18. Spielmann H, Muller UJ. Investigations on cyclophosphamide during the preimplantation period. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation. Teratology 1981; 23: 7-13.
19. Slott VL, Hales BF. Enhancement of the teratogenicity of acrolein, but not phosphoramide mustard, by glutathione depletion in rat embryos in vitro. Biochem Pharmacol 1987; 36: 2019-25.
20. Manson JM, Simmons R. In vitro metabolism of cyclophosphamide in limb bud culture. Teratology 1979; 19: 149-58.
21. Wiger R, Trygg B, Holme JA, et al. Toxic effects of cyclophosphamide in differentiating chicken limb bud cell culture using rat liver 9000 g supernatant or rat liver cells as an activation system: an in vitro short-term test for proteratogen. Teratology 1989; 40: 603-13.
22. Roberts JC, Francetic DJ. Chemoprotection against cyclophosphamide-induced urotoxicity: ribose-cysteine. Anticancer Res 1994; 14: 383-8.
23. Roberts JC, Francetic DJ, Zera RT. Chemoprotection against cyclophosphamide-induced urotoxicity; comparison of nine thiol protective agents. Anticancer Res 1994; 14: 389-96.
24. Reznik G, Hecht J. Teratogenic effect of cyclophosphamide and the preventive effects of pyrithinoldehydrochloride monohydrate. Arzneim Forsch 1979; 29: 479-82.
25. Schubert J. Tierexperimentalle Untersuchungen zur Frage der medikamentosen Prophylaxe kongenitaler Spaltbildungen. Zahr Mund Kieferheilkd 1977; 65: 638-41.
26. Schubert J. Zur Wertigkeit Verschiedene Medikamente in der Missibildungspravention. Zahn Mund Kieferheilkd 1986; 74: 43-6.
27. Dostal M, Schubert J. Further studies on protective effects of vitamins in cyclophosphamide-induced cleft palate. Int J Oral Maxillofac Surg 1990; 19: 308-11.
28. Shah RM. Morphological, cellular and biochemical aspects of differentiation of normal and teratogen-treated palate in hamster and chick embryos. Curr Top Dev Biol 1984; 19: 103-35.
29. Ferguson MWJ. Palate development. Development 1988; 103; 41-60 (Suppl).
30. Greene RM. Signal transduction during craniofacial development. Crit Rev Toxicol 1989; 20: 153-74.
31. Shah RM. Differentiation of cyclophosphamide-treated hamster secondary palate: ultrastructural and biochemical observations. Am J Anat 1990; 187: 1-11.
32. Burdett DN, Shah RM. Gross and cellular analysis of 6-mercaptopurine-induced cleft palate in hamster. Am J Anal 1988; 181: 179-94.
33. Shah RM, Crawford BJ, Greene RM, et al. In vitro development of the hamster and chick secondary palate. J Craniofac Genet Dev Biol 1985; 5: 299-314.
34. Benkhaial G, Shah RM. Effects of 5-fluorouracil on collage synthesis in the developing palate of hamster. Anti-Cancer Drugs 1994; 5: 99-140.
35. Gornall AG, Bardawill CJ, David MM, et al. Determination of serum protein by means of the Biuret reagent. J Biol Chem 1949; 177: 751-66.
36. Young AV, Hehn BM, Cheng KM, et al. A comparative study on the effects of 5-fluorouracil on glycosaminoglycan synthesis during palate development in quail and hamster. Histol Histopath 1994; 9: 515-23.
37. Derby M, Pintar J. The histochemical specificity of Streptomyces hyaluronidase and chondroitinase ABC. Histochem J 1978; 10: 529-37.
38. Turley E, Hollenburg M, Pratt RM, et al. Effect of epidermal growth factor/urogastrone on glycosaminoglycan synthesis and accumulation in vitro in the developing mouse palate. Differentiation 1985; 28: 279-85.
39. Shah RM. A cellular mechanism for the palatal shelf reorientation from a vertical to a horizontal plane in hamster: light and electron microscopic study. J Embryol Exp Morph 1979; 58: 1-13.
40. Fantel AG, Greenaway JC, Juchau MR, et al. Teratogenic bioactivation of cyclophosphamide in vitro. Life Sci 1979; 25: 67-72.
41. Hales BF. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochrome P-450. Teratology 1981; 211: 1-11.
42. Greenaway JC, Fantel AG, Shepard TH, et al. The in vitro teratogenicity of cyclophosphamide in rat embryos. Teratology 1982; 25: 335-43.
43. Greenaway JC, Mirkes PE, Mirkes EA, et al. The effect of oxygen concentration on the teratogenicity of salicylate, niridazole, cyclophosphamide, and phosphoramide mustard in rat embryos in vitro. Teratology 1985; 32: 287-95.
44. Mirkes PE, Greenaway JC, Shepard TH, et al. A kinetic analysis of rat embryo response to cyclophosphamide exposure in vitro. Teratology 1983; 28: 249-56.
45. 3H) cyclophosphamide by rat embryos in vitro. Teratology 1985; 31: 373-80.
46. Oglesby LA, Ebron MT, Beyer PE, et al. Co-culture of rat embryos and hepatocytes: in vitro detection of a proteratogen. Teratogen Carcinogen Mutagen 1986; 6: 129-38.
47. Lieber MM, Ames MM, Powis GW, et al. Anticancer drug testing in vitro: use of an activating system with the human tumor stem cell assay. Life Sci 1981; 28: 287-93.
48. Chaudhry AP, Siar S. In vitro study of fusion of palatal shelves in A/Jax mouse embryos. J Dent Res 1967; 46: 257-60.
49. Fried W, Barone J. Residual marrow damage following therapy with cyclophosphamide. Exp Hematol 1980; 8: 610-4.
50. De Jong JP, Nikkels PG, Brockbank KG, et al. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow derived stromal and hemopoetic progenitor cell classes. Cancer Res 1985; 115: 4001-8.
51. Siena S, Castro-Malaspina H, Gulati SC, et al. Effects of in vitro purging with 4-hydroxycyclophosphamide on the haematopoietic microenvironmental elements of human bone marrow. Blood 1985; 65: 655-62.
52. Chernoff N, Rogers JM, Alles AJ, et al. Cell cycle alterations and cell death in cyclophosphamide teratogenesis. Teratogen Carcinogen Mutagen 1989; 9: 199-209.
53. Frances BM, Rogers JM, Sulik KK, et al. Cyclophosphamide teratogenesis: Evidence for compensatory responses to induced cellular toxicity. Teratogenesis 1990; 42: 473-82.
54. Lopez M, Mary JY, Sainteny F, et al. In vitro purging of bone marrow with mafosfamide syndergizes with in vivo chemotherapy to delay the haematological recovery in a murine model of autologus bone marrow transplantation. Exp Hematol 1993; 21: 311-8.
55. Davidoff AN, Mendelow BV. Cell cycle disruption and apoptosis induced by the cyclophosphamide derivative mosfosfamide. Exp Hematol 1993; 21: 922-7.
56. Kachel D, Martin WJ. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther 1994; 268: 42-6.
57. Mirkes PE, Fantel AG, Greenaway JC, et al. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-hydroxycyclophosphamide on rat embryos cultured in vitro. Toxicol Appl Pharmacol 1981; 58: 322-30.
58. Little SA, Mirkes PE. DNA cross-linking and single strand breaks induced by teratogenic concentration of 4-hydroxycyclophosphamide and phosphoramide mustard in post-implantation rat embryos. Cancer Res 1987; 47: 5421-6.
59. Hales BF. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro. Teratology 1989; 110: 11-20.
60. Meyn RE, Stephens LC, Hunters NR, et al. Induction of apoptosis in murine tumors by cyclophosphamide. Cancer Chemother Pharmacol 1994; 33: 410-4.
61. Foreman DM, Sharp PM, Ferguson MWJ, et al. Comparative biochemistry of mouse and chick secondary palate development in vivo and in vitro with particular emphasis on extracellular matrix molecules on the effects of growth factors on their synthesis. Arch Oral Biol 1991; 36: 457-71.
62. Morris-Wiman J, Brinkley L. An extracellular matrix infrastructure provides support for during secondary palatal shelf remodelling. Anat Rec 1992; 234: 575-86.
63. Morris-Wiman J, Brinkley L. Rapid changes in the extracellular matrix accompany in vitro palatal shelf remodelling. Anat Embryol 1993; 188: 75-85.
64. Benkhaial GS, Cheng KM, Shah RM, et al. Effects of 5-fluorouracil on collagen synthesis during quail secondary palate development. J Craniofac Genet Dev Biol 1993; 13: 6-17.
65. 3H-proline uptake in the palate of normal mice and in the palate of mice treated with hydrocortisone. J Dent Res 1969; 48: 1039-41.
66. Pratt RM, King CTG. Collagen synthesis in the secondary palate of the developing rat. Arch Oral Biol 1971; 16: 1181-5.
67. Shapira Y, Shoshan S. The effect of cortisone on collagen synthesis in the secondary palate of mice. Arch Oral Biol 1972; 17: 1699-703.
68. Hassell JR, Orkin R. Synthesis and distribution of collagen in the rat palate during shelf elevation. Dev Biol 1976; 49: 80-8.
69. Larsson K. Closure of secondary palate and its relation to sulpho-mucopolysaccharides. Acta Odont Scand 1962; 4: 349-67 (Suppl 31).
70. Jacobs RM. Histochemical study of morphogenesis and teratogenesis of the palate in mouse embryos. Anat Rec 1964; 19: 6791-698.
71. Nanda R. The role of sulfated mucopolysaccharides in cleft palate formation. Teratology 1971; 3: 237-44.
72. Pratt RM, Goggins J, Wilks A, et al. Acid mucopolysaccharide synthesis in the secondary palate of the developing rat at the time of rotation and fusion. Dev Biol 1973; 32: 230-7.
73. Brinkley L, Vickerman M. The effects of ch orcyclizine-induced alteration of glycosaminoglycans on mouse palatal shelf elevation in vivo and in vitro. J Embryo Exp Morph 1982; 69: 193-213.
74. Knudson T, Bulleit R, Zimmerman E, et al. Histochemical localization of glycosaminoglycans during morphogenesis of the secondary palate in mice. Anat Embryol 1988; 173: 137-42.
75. Dostal M. Cleft palate induced with cyclophosphamide in the mouse embryo. Folia Morph 1982, 30: 315-21.
76. Dostal M. Cyclophosphamide-induced c eft palate: effects of single and consecutive administration. Folia Morph 1985; 33: 103-10.